Authors:
NARASIMHAN C
SRA J
MAGLIO C
MCCANN S
DESHPANDE S
PANOTOPOULOS PT
BIEHL M
Citation: C. Narasimhan et al., CLINICAL SPECTRUM OF NEUROCARDIOGENIC SYNCOPE - EFFECT OF TREATMENT ON RELATED SYMPTOMS, Circulation, 94(8), 1996, pp. 1946-1946
Authors:
BRIONES J
URBANOISPIZUA A
LAWLER M
ROZMAN C
GARDINER N
MARTINEZ C
MCCANN S
MONTSERRAT E
Citation: J. Briones et al., HIGH-FREQUENCY OF COMPLETE DONOR CHIMERISM FOLLOWING ALLOGENEIC TRANSPLANTATION OF CD34-BLOOD PROGENITOR CELLS (ALLO PBPCT( SELECTED PERIPHERAL)CD34+)/, Blood, 88(10), 1996, pp. 442-442
Authors:
MCCANN S
SULLIVAN J
GUERRA J
ARCINAS M
BOXER LM
Citation: S. Mccann et al., REPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES, The Journal of biological chemistry, 270(40), 1995, pp. 23785-23789
Authors:
DORN J
MCCANN S
TREVISAN M
CERNY F
EPSTEIN L
Citation: J. Dorn et al., COMPARISON OF ENERGY-EXPENDITURE ESTIMATION BETWEEN 2 PHYSICAL-ACTIVITY RECALL QUESTIONNAIRES AND THE TRITRAC(R) ACCELEROMETER, American journal of epidemiology, 141(11), 1995, pp. 48-48
Citation: S. Mccann et al., PROGNOSTIC-SIGNIFICANCE OF MIXED HEMATOPOIETIC CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Chinese medical journal, 107(10), 1994, pp. 729-730
Authors:
BACIGALUPO A
GLUCKMAN E
MORI PG
SARACCO P
DELLAVOLPE A
LOCATELLI G
LIPPI A
MCCANN S
GABBAS A
TODESCHINI A
CAROTENUTO M
IACOPINO G
COSER P
ARCESE G
Citation: A. Bacigalupo et al., ANTILYMPHOCYTE GLOBULIN (ALG), CYCLOSPORINE (CYA) AND G-CSF IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - A PILOT-STUDY OF THE EBMT SAA WORKING PARTY, Experimental hematology, 21(8), 1993, pp. 1081-1081
Authors:
SCHREZENMEIER H
MARIN P
RAGHAVACHAR A
MCCANN S
HOWS J
GLUCKMAN E
NISSEN C
VANTVEERKORTHOF ET
LJUNGMAN P
HINTERBERGER W
VANLINT MT
FRICKHOFEN N
BACIGALUPO A
Citation: H. Schrezenmeier et al., RELAPSE OF APLASTIC-ANEMIA AFTER IMMUNOSUPPRESSIVE TREATMENT - A REPORT FROM THE EUROPEAN BONE-MARROW TRANSPLANTATION GROUP SAA WORKING PARTY, British Journal of Haematology, 85(2), 1993, pp. 371-377
Authors:
LJUNGMAN P
DEWITTE T
VERDONCK L
GAHRTON G
FREYCON F
GRAVETT P
MCCANN S
MORGENSTERN HG
NIKOSKELAINEN J
POWLES R
PROCTOR SJ
VOLIN L
ZWAAN F
GRATWOHL A
Citation: P. Ljungman et al., BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOBLASTIC-LEUKEMIA - AN EBMT-LEUKEMIA-WORKING-PARTY PROSPECTIVE ANALYSIS FROM HLA-TYPING, British Journal of Haematology, 84(1), 1993, pp. 61-66
Authors:
LINK H
FAUSER A
HUBNER G
BACIGALUPO A
BOOGAERTS M
BURDACH S
CARELLA A
FERRANT A
GOLDSTONE A
GORIN N
KRIEGER O
LINKESCH W
MANDELLI F
MCCANN S
REIFFERS J
SLAVIN S
STEWARD W
TURA S
ZINTL F
SCHINDELKUNZEL F
HEINRICHS H
Citation: H. Link et al., CLINICAL BONE-MARROW TRANSPLANTATION .3. RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE PLACEBO-CONTROLLED TRIAL IN EUROPE, Blood, 82(10), 1993, pp. 10000284-10000284